Trial Profile
An open-label randomized controlled study on the efficacy and safety of vitamin D plus peginterferon alpha 2a/ribavirin in elder women with chronic hepatitis C
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 08 Feb 2011
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Ribavirin (Primary) ; Alfacalcidol
- Indications Hepatitis C
- Focus Therapeutic Use
- 08 Feb 2011 New trial record